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During the sequential steps of metastases, tumour cells
encounter various host cells (platelets, lymphocytes or
endothelial cells) and/or extracellular matrix and basement
membrane components (fibronectin or laminin) (Fidler,
1984). As a result of adhesive interaction, this encounter may
lead to a multicellular embolus formation which can
subsequently enhance the survival, arrest and invasiveness of
tumour cells (Fidler, 1984; Terranova et al., 1982, 1984).
Since specific interactions between tumour cells and host
cells or components are fundamental events in the metastatic
process, the adhesion and detachment of the cells are
therefore thought to be of prime importance for the control
of the cellular functions of diverse cell types, including cells
which are highly metastatic (Terranova et al., 1984).
The molecules involved in the adhesion of both normal
and tumour cells have been studied quite intensively in
recent years. Fibronectin (Kornblihtt et al., 1985), vitro-
nectin (Suzuki et al., 1985) and laminin (Sasaki et al., 1987;
Sasaki & Yamada, 1987) have been identified by molecular
cloning as the primary structures of cell adhesion proteins.
Common or characteristic core sequences responsible for
cellular recognition in molecules have also been found to
contribute to cell adhesion, spreading or migration
(McCarthy & Furcht, 1984; Yamada & Kennedy, 1984;
Rouslahti & Pierschbacher, 1987). The co-incubation of
tumour cells with purified laminin followed by i.v. injection
has been found to enhance pulmonary metastases, whereas a
fragment of laminin inhibits the metastases (Barsky et al.,
1984). More recently, synthetic peptides containing core
sequences (arg-gly-asp derived from fibronectin or tyr-ile-gly-
ser-arg derived from laminin) have been shown to exhibit a
similar inhibition of lung metastases (Humphries et al., 1986;
Iwamoto et al., 1987). This evidence has prompted us to
carry out an attempt to regulate more efficiently the
mechanism involved in the adhesion of tumour cells during
the metastatic process.
It is well known that the introduction of plural peptides
(for example, peptide hormones) into carrier proteins can
sometimes augment the activity of the peptide hormone
because of the co-operative interaction between the
molecules, although at the same time this may reduce
molecular flexibility and mobility and consequently lead to a
decrease in the affinity between the peptide and the specific
receptors. Drastically high activity of the polymerised
functional molecule has also been reported as a common
phenomenon in the field of polymer catalyst or enzyme-
model polymers, and has come to be called the 'polymer
effect' (Kunitake & Okahata, 1976). We have found that
poly-L-arg (-5,000 daltons in average molecular weight) is
able to activate mouse peritoneal macrophages to become
cytotoxic against tumour cells more effectively than (L-
arg)12, (L-arg)6 and L-arg by i.p. administration (J. lida et
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al., manuscript submitted); this suggests that the polymer-
isation of L-arg plays a role in inducing the tumoricidal
activity of macrophages. We therefore synthesised some
polypeptides unique to our laboratory, poly(arg-gly-asp) or
poly(tyr-ile-gly-ser-arg), which consist of repeated structures
of the arg-gly-asp or tyr-ile-gly-ser-arg peptide sequences
respectively, and poly(arg, gly, asp) which consists of the
same amino acid components as poly(arg-gly-asp) but has a
random sequence of amino acids. Polypeptides used in this
study were prepared by the synthesis of the monomer
peptides of arg-gly-asp or tyr-ile-gly-ser-arg sequences by the
conventional method and a subsequent polymerisation
reaction. t-Butoxycarbonyl (t-boc), mesitylenesulphonyl (mts)
and methyl (CH3) groups were employed as the protecting
groups for a-amino guanidino and a-carboxyl groups. The
benzyl (bzl) group was employed to protect the side-chain
functional groups of asp, tyr and ser residues. The purity of
the peptides were confirmed by thin layer chromatography
and elemental analysis. Polymerisation of monomer peptide
was carried out with diphenylphosphorylazide, as we have
described elsewhere (Nishi et al., 1980). The removal of the
side-chain protecting groups from the resulting sequential
polypeptides was carried out with a methansulphonic acid-
anisole mixture for the initial polypeptide and with a tri-
fluoromethanesulphonic acid-thioanisole-trifluoroacetic acid
mixture for the latter polypeptide. The consequent methan-
sulphonate or trifluoromethanesulphonate was converted to
hydrochloride with Amberlite IRA 400 (Cl form) to give the
final product. The complete removal of the protecting
groups was confirmed by IR. The final products showed a
typical polypeptide pattern. All the amino acids used in this
study were of the L-form type. In the sequence of poly(arg-
gly-asp), a gly residue is always left hetween the arg and asp
residues, and the -arg-gly-asp- sequence exists as a block. In
the sequence of poly(arg, gly, asp), on the other hand, these
amino acids are randomly arranged without rule, and the
probability of an -arg-gly-asp- sequence is statistically very
small. Poly(arg-gly-asp) and its random polypeptide weigh
- 5,000 daltons while poly(tyr-ile-gly-ser-arg) weighs
-10,000 daltons; this was assessed by viscometric
measurements and SDS-polyacrylamide gel electrophoresis;
they are then dissolved in phosphate-buffered saline (PBS)
before use.
We first examined the adhesive capability of B16-BL6
melanoma cells to the polypeptide. 125I-iododeoxyuridine
(1251-IUdR) labelled B16-BL6 cells suspended in a serum-
free MEM medium were added to microculture wells pre-
coated with polypeptides or mouse fibronectin, and
incubated at 37°C for 20min. After they had been washed to
remove unattached cells, the number of remaining substrate-
bound tumour cells was calculated by measuring their radio-
activity (Saiki et al., 1986). Poly(arg-gly-asp) and fibronectin
promoted the adhesion of B16-BL6 cells (Table I). However,
few B16-BL6 cells attached themselves to the substrates
coated with poly(arg, gly, asp) or to bovine serum albumin
(BSA) used as a negative control. To investigate the
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Table I Adhesion of B16-BL6 melanoma cells to polypeptide- or fibronetin-coated substrates
Binding capacity
Coated with Co-incubated with No. of cells bound/substrate+s.d.a
Fibronectin 5,849+513
Poly(arg-gly-asp) 7,967+910
Poly(arg, gly, asp) 1,750+395
BSA 1,239+347
Fibronectin +arg-gly-asp 500jugml - 3,708+265(37%)
100 5,320+ 52
+his-gly-gly 500 6,133 +787
+poly(arg-gly-asp) 500 3,715+231(36%)
100 3,687+229(37%)
125I-IUdR labelled B16-BL6 cells (2 x 104) suspended in serum-free medium were added to wells
coated with 5jugml- fibronectin, 20pgml 1 polypeptides or 1% BSA in PBS, in the absence or
presence of peptides. After 20min incubation, non-adherent cells were washed away and the remaining
adhered cells were counted. aMean +s.d. in triplicate cultures. The results of a representative sample of
four independent experiments are shown.
specificity of cell adhesion to fibronectin-coated substrate, we
carried out a cell adhesion assay in the presence of
tripeptides or polypeptides. Arg-gly-asp and poly(arg-gly-
asp) were specifically able to inhibit the adhesion of tumour
cells to fibronectin-coated substrates, whereas the unrelated
sequencing tripeptide his-gly-gly were not able to do so. The
inhibition was caused by co-incubation with increasing
amounts of the arg-gly-asp sequence in a dose-dependent
manner or by the addition of 5mM EDTA (I. Saiki et al.,
manuscript submitted). Poly(arg-gly-asp) showed a clear
ability to inhibit the cell adhesion to fibronectin several times
on a dose (weight), and did so more effectively than arg-gly-
asp tripeptide. These results indicate that the cell-adhesion
promoting activity of poly(arg-gly-asp) as well as fibronectin
depends on the specific mechanism mediated by the arg-gly-
asp sequence in a cation-dependent manner; this suggests
that the cell surface receptor responsible for adhesion is able
to recognise this sequence in the adhesion molecule (Cheresh
et al., 1987).
We next considered whether our synthetic polypeptides are
able or not to inhibit lung metastases caused by the i.v.
injection of tumour cells. To do this, we used two highly
metastatic tumour cells, B16-BL6 melanoma and Lewis lung
carcinoma (3LL). Co-injection of 500jg poly(arg-gly-asp)
with 5 x 104 B16-BL6 cells or 3 x 105 3LL cells caused a
significant reduction of lung metastases in C57BL/6 mice
(P<0.001 respectively), but 500 g of either poly(arg, gly,
asp) or arg-gly-asp tripeptide did not (Table II).
Nevertheless, a significant inhibition of lung metastases was
observed when the dose (3,000pgmouse-1) of arg-gly-asp
tripeptide was increased (P<0.001). The inhibition caused by
tripeptide is similar to one reported previously, that
substantial inhibition of tumour metastases of B16-FIO cells
can be obtained with 3mg of pentapeptide containing arg-
gly-asp (Humphries et al., 1986). Poly(tyr-ile-gly-ser-arg) at
all doses used in this study inhibited significantly the lung
metastases, but tyr-ile-gly-ser-arg pentapeptide did not
inhibit the metastases at any dose except one of 200 ig
(Table II). Similar inhibitory effects were obtained in the
experimental metastasis model using 3LL. These results thus
clearly demonstrate that poly(arg-gly-asp) or poly(tyr-ile-gly-
ser-arg) could inhibit the lung metastases -5-10 times more
efficiently than the arg-gly-asp or tyr-ile-gly-ser-arg peptides.
In addition, the i.v. injection of poly(arg-gly-asp) following
an injection of B16-BL6 cells (i.e. sequential separate
injection) was almost as effective a means of reducing the
tumour colonies in the lung as the co-injection (premixing)
of cells and poly(arg-gly-asp) (I. Saiki et al., manuscript
submitted). The polypeptides used in this study had no
harmful cytotoxic effects on such cells as the B16-BL6 cells,
3LL cells, mouse red blood cells or thymocytes, nor did it
affect their cell growth or the aggregation of the serum
proteins. We have also observed that the inhibition of lung
metastases can be induced by co-injection with various
soluble polypeptide analogues containing the arg-gly-asp
sequence, and even with a polypeptide entrapped
(insolubilised) within non-phagocytisable multilamellar
liposome membranes (I. Saiki et al., manuscript submitted).
These findings may imply that poly(arg-gly-asp) or poly(tyr-
ile-gly-ser-arg) have higher affinity for adhesion receptors or
have molecule conformations or environments of polypeptide
more appropriate to the adhesion receptors than arg-gly-asp
or tyr-ile-gly-ser-arg peptides. These points need to be
studied further.
In our next experiment, we examined whether or not the
lung metastases of B16-BL6 melanoma could be inhibited by
the intralesional administration of polypeptides into the-
established primary tumour in the spontaneous metastasis
model. Poly(arg-gly-asp) was administered intratumorally (or
intralesionally) into the right hind footpad with an advanced
primary tumour at various times following tumour
inoculation, after which, on day 21, the primary tumours
were surgically removed. Tumour colonies in the lung were
monitored 14 days after tumour excision. The results of a
representative sample of the three independent experiments
are shown in Table III. Single or multiple intratumoral
administrations of poly(arg-gly-asp) on day 1, day 7 or day
7, 10, 13, 16 caused a marked reduction of tumour colonies
of B16-BL6 melanoma, but did not affect the growth (size)
of primary tumours on day 21 compared with untreated
control. The administration of random polypeptide,
poly(arg, gly, asp), on day 7 after tumour inoculation was
not able to inhibit the lung metastases. These results indicate
that the inhibition of lung metastases by means of the
intratumoral administration of poly(arg-gly-asp) may depend
on the inhibition of active migration of tumour cells away
from the primary tumour site. Furthermore, we also
observed that multiple systemic administration of poly(arg-
gly-asp) on days 7, 9, 11, 13, 15, 17 and 19 after an
intrafootpad inoculation of the tumour led to a significant
decrease of the lung tumour colonisation in the spontaneous
model (I. Saiki et al., manuscript submitted).
The exact mechanism responsible for the inhibition of lung
metastases by these polypeptides may thus be more complex
than a simple blockage of cell adhesion. We have recently
observed that poly(arg-gly-asp) inhibits tumour-induced
platelet aggregation which in turn is responsible for the
enhancement of tumour cell arrest in the capillaries (Gasic et
al., 1973; Jamieson et al., 1987), but does not directly
provoke the aggregation of platelets (Saiki et al., 1988).
Poly(tyr-ile-gly-ser-arg) is specifically able to inhibit the
penetration of melanoma cells to the membrane filters
precoated with laminin on the lower surface (haptotactic
migration) in a dose-dependent manner (Murata et al.,
1988). Some possibilities also include the acceleration of
release of arrested tumour cells from the lung and the
inhibition by polypeptide of their lodgement.
In conclusion, we demonstrated that unique polypeptides196 I. SAIKI et al.
Table II Effect of polypeptides on experimental lung metastases induced by injection with
metastatic tumour cells
Dose No. of lung metastases
Tumours Administered i.v. witha (pgmouse& ) Mean+s.d. (range) pb
BJ6-BL6
Expt 1 Untreated (PBS) - 91 +19 (64-112)
Poly(arg-gly-asp) 500 23 + 3 (20- 28) <0.001
Arg-gly-asp 3,000 18+24 (1- 52) <0.001
500 69+21 (50-102)
Poly(arg, gly, asp) 500 65 + 4 (64- 68)
Expt 2 Untreated (PBS) - 115+24 (86-149)
Poly(tyr-ile-gly-ser-arg) 200 0 (0) <0.001
100 19+ 9 (10- 32) <0.001
20 43+ 13 (24- 56) <0.001
5 81+ 9 (67- 89) <0.02
Tyr-ile-gly-ser-arg 200 35+16 (18- 60) <0.001
100 101 +17 (77-122)
20 109+39 (61-164)
5 128+31 (104-180)
3LL Untreated (PBS) - 139+19 (113-158)
Poly(arg-gly-asp) 500 34+ 7 (26- 41) <0.001
Poly(tyr-ile-gly-ser-arg) 100 14+11 (2- 28) <0.001
Tyr-ile-gly-ser-arg 100 123 +45 (74-187)
aB16-BL6 cells (5 x 104 per 0.2ml) or 3LL (3 x 105 per 0.2ml) were injected i.v. with or
without admixing with polypeptides into five mice per group. Lung tumour colonies were
examined 14 days later. The results of a representative sample of several independent
experiments are shown. bCompared with untreated control (PBS) by Student's two-tailed
test.
Table III Therapeutic effect of polypeptides on spontaneous lung metastases by intrafootpad administration of
B16-BL6 melanoma cells
Primary tumour
Dose size on day 21 No. of lung metastases
Treated with (ugmouse& ) Timing (mm+s.d.) Mean+s.d. (range) pa
Untreated (PBS) 10+4 129+38 (78-180)
Poly(arg-gly-asp) 100 on day 1 8+4 24+17 (4- 49) <0.001
on day 7 9+3 29+22 (0- 50) <0.001
on day 14 10+4 120+29 (79-155)
on day 20 8+3 131 +79 (75-247)
_50x4 on day 7, 10, 13, 16 8+3 26+29 (0- 68) <0.01
Poly(arg, gly, asp) 100 on day 7 11 +3 158 +62 (117-230)
Five C57BL/6 mice per group were administered intratumorally with 100 or 50pg of polypeptides (0.05ml) at the
indicated times after the intrafootpad injection (5 x 105 per 0.05 ml) of B16-BL6 melanoma cells. Primary tumours
were surgically removed on day 21 and mice were killed two weeks after tumour excision. The results of a
representative of three experiments are shown. aCompared with the untreated group by Student's two-tailed t test.
containing the repetitive structure of arg-gly-asp or tyr-ile-
gly-ser-arg core sequences are able to inhibit tumour lung
metastases in experimental and spontaneous metastases
models, possibly by means of their ability to interfere with
the cellular adhesive process of metastases, and that multi-
valent units of the arg-gly-asp or tyr-ile-gly-ser-arg core
sequences are able to promote the inhibition of the lung
metastases more dramatically than single units: this evidence
indicates the prominent effect of sequential polymerisation.
The mechanism for the inhibition of lung metastases by
these polypeptides is now being examined in detail. A.core
sequence containing polypeptides taken from cell adhesion
molecules may thus provide a promising basis for the
prevention of cancer metastases.
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